GEMIGNANI, FEDERICA Statistiche

GEMIGNANI, FEDERICA  

DIPARTIMENTO DI BIOLOGIA  

Mostra records
Risultati 1 - 20 di 147 (tempo di esecuzione: 0.033 secondi).
Titolo Data di pubblicazione Autore(i) File
Computational modeling and experimental validation of the interaction between tumor biomarker mesothelin and an engineered targeting protein with therapeutic activity 1-gen-2025 Piccardi, Margherita; Butera, Valeria; Sardo, Ignazio; Landi, Stefano; Gemignani, Federica; Barone, Giampaolo; Spinello, Angelo; Moore, Sarah J.
Decoding the role of mesothelin in tumor dynamics and targeted treatment innovations 1-gen-2025 Silvestri, Roberto; Colucci, Emanuela; Piccardi, Margherita; Landi, Stefano; Gemignani, Federica
Development of a Mesothelin-Binding Engineered Scaffold Protein as a Theranostic for Pleural Mesothelioma 1-gen-2025 Silvestri, Roberto; Piccardi, Margherita; Laurenza, Alessia; Rea, Filomena; Sirois, Allison R.; Lari, Martina; Bartoli, Francesco; Signore, Giovanni; Tedeschi, Lorena; Ferraro, Elisabetta; Erba, Paola Anna; Giovannoni, Roberto; Landi, Stefano; Gemignani, Federica; Moore, Sarah J.
Transcriptomic Profiling of the Tumor Microenvironment in High-Grade Serous Carcinoma: A Pilot Study of Morphologic and Molecular Distinctions Between Classic and SET Patterns 1-gen-2025 Giannini, Riccardo; Bartoli, Francesco; Ieso, Katia De; Camacci, Tiziano; Bertolucci, Andrea; Piccini, Lorenzo; Rreka, Erion; Volterrani, Duccio; Gemignani, Federica; Landi, Stefano; Ugolini, Clara; Lippolis, Piero Vincenzo; Faviana, Pinuccia
BAG2, MAD2L1, and MDK are cancer-driver genes and candidate targets for novel therapies in malignant pleural mesothelioma 1-gen-2024 Bisceglia, Luisa; Morani, Federica; Guerrieri, Lara; Santoni-Rugiu, Eric; Çakılkaya, Pınar; Scatena, Cristian; Scarpitta, Rosa; Engelholm, Lars H.; Behrendt, Niels; Gemignani, Federica; Landi, Stefano
Comparative analysis of genetic variants in pleural fluids and solid tissue biopsies of pleural mesothelioma patients: Implications for molecular heterogeneity assessment 1-gen-2024 Silvestri, Roberto; Rea, Filomena; Vitiello, Marianna; Moretti, Gabriele; Aprile, Vittorio; Lucchi, Marco; Aretini, Paolo; Mazzanti, CHIARA MARIA; Landi, Stefano; Gemignani, Federica
Genetically determined telomere length in monoclonal gammopathy of undetermined significance, multiple myeloma risk and outcome 1-gen-2024 Giaccherini, Matteo; Clay-Gilmour, Alyssa I; Liotti, Romano; Macauda, Angelica; Gentiluomo, Manuel; Brown, Elizabeth E; Machiela, Mitchell J; Chanock, Stephen J; Hildebrandt, Michelle A T; Norman, Aaron D; Manasanch, Elisabet; Rajkumar, S Vincent; Hofmann, Jonathan N; Berndt, Sonja I; Bhatti, Parveen; Giles, Graham G; Ziv, Elad; Kumar, Shaji K; Camp, Nicola J; Cozen, Wendy; Slager, Susan L; Canzian, Federico; Gemignani, Federica; Vachon, Celine M; Campa, Daniele
Polymorphism Pro64His within galectin-3 has functional consequences at proteome level in thyroid cells 1-gen-2024 Silvestri, Roberto; Zallocco, Lorenzo; Corrado, Alda; Ronci, Maurizio; Aceto, Romina; Ricci, Benedetta; Cipollini, Monica; Dell'Anno, Irene; De Simone, Chiara; De Marco, Giuseppina; Ferrarini, Eleonora; Beghelli, Daniela; Mazzoni, Maria Rosa; Lucacchini, Antonio; Gemignani, Federica; Giusti, Laura; Landi, Stefano
Strategies for single base gene editing in an immortalized human cell line by CRISPR/Cas9 technology 1-gen-2024 Corrado, Alda; Aceto, Romina; Miglietta, Simona; Silvestri, Roberto; Dell'Anno, Irene; Lepori, Irene; Ricci, Benedetta; Romei, Cristina; Giovannoni, Roberto; Poliseno, Laura; Evangelista, Monica; Vitiello, Marianna; Cipollini, Monica; Elisei, Rossella; Landi, Stefano; Gemignani, Federica
The breast cancer tumor microenvironment and precision medicine: immunogenicity and conditions favoring response to immunotherapy 1-gen-2024 Nicolini, Andrea; Ferrari, Paola; Silvestri, Roberto; Gemignani, Federica
A pleiotropic variant in DNAJB4 is associated with multiple myeloma risk 1-gen-2023 Dicanio, Marco; Giaccherini, Matteo; Clay-Gilmour, Alyssa; Macauda, Angelica; Sainz, Juan; Machiela, Mitchell J; Rybicka-Ramos, Malwina; Norman, Aaron D; Tyczyńska, Agata; Chanock, Stephen J; Barington, Torben; Kumar, Shaji K; Bhatti, Parveen; Cozen, Wendy; Brown, Elizabeth E; Suska, Anna; Haastrup, Eva K; Orlowski, Robert Z; Dudziński, Marek; Garcia-Sanz, Ramon; Kruszewski, Marcin; Martinez-Lopez, Joaquin; Beider, Katia; Iskierka-Jazdzewska, Elżbieta; Pelosini, Matteo; Berndt, Sonja I; Raźny, Małgorzata; Jamroziak, Krzysztof; Rajkumar, S Vincent; Jurczyszyn, Artur; Vangsted, Annette Juul; Collado, Pilar Garrido; Vogel, Ulla; Hofmann, Jonathan N; Petrini, Mario; Butrym, Aleksandra; Slager, Susan L; Ziv, Elad; Subocz, Edyta; Giles, Graham G; Andersen, Niels Frost; Mazur, Grzegorz; Watek, Marzena; Lesueur, Fabienne; Hildebrandt, Michelle A T; Zawirska, Daria; Ebbesen, Lene Hyldahl; Marques, Herlander; Gemignani, Federica; Dumontet, Charles; Várkonyi, Judit; Buda, Gabriele; Nagler, Arnon; Druzd-Sitek, Agnieszka; Wu, Xifeng; Kadar, Katalin; Camp, Nicola J; Grzasko, Norbert; Waller, Rosalie G; Vachon, Celine; Canzian, Federico; Campa, Daniele
The involvement of Purkinje cells in progressive myoclonic epilepsy: Focus on neuronal ceroid lipofuscinosis 1-gen-2023 Bernardi, Sara; Gemignani, Federica; Marchese, Maria
A Drug Screening Revealed Novel Potential Agents against Malignant Pleural Mesothelioma 1-gen-2022 Dell'Anno, I.; Melani, A.; Martin, S. A.; Barbarino, M.; Silvestri, R.; Cipollini, M.; Giordano, A.; Mutti, L.; Nicolini, A.; Luzzi, L.; Aiello, R.; Gemignani, F.; Landi, S.
Genetic signature of differentiated thyroid carcinoma susceptibility: a machine learning approach 1-gen-2022 Brigante, Giulia; Lazzaretti, Clara; Paradiso, Elia; Nuzzo, Federico; Sitti, Martina; Tüttelmann, Frank; Moretti, Gabriele; Silvestri, Roberto; Gemignani, Federica; Försti, Asta; Hemminki, Kari; Elisei, Rossella; Romei, Cristina; Zizzi, Eric Adriano; Deriu, Marco Agostino; Simoni, Manuela; Landi, Stefano; Casarini, Livio
Germline genetic variability in pancreatic cancer risk and prognosis 1-gen-2022 Gentiluomo, M.; Canzian, F.; Nicolini, A.; Gemignani, F.; Landi, S.; Campa, D.
Integrative Organelle-Based Functional Proteomics: In Silico Prediction of Impaired Functional Annotations in SACS KO Cell Model 1-gen-2022 Morani, Federica; Doccini, Stefano; Galatolo, Daniele; Pezzini, Francesco; Soliymani, Rabah; Simonati, Alessandro; Lalowski, Maciej M; Gemignani, Federica; Santorelli, Filippo M
Maternal anthropometric variables and clinical factors shape neonatal microbiome 1-gen-2022 Farinella, R.; Rizzato, C.; Bottai, D.; Bedini, A.; Gemignani, F.; Landi, S.; Peduzzi, G.; Rosati, S.; Lupetti, A.; Cuttano, A.; Moscuzza, F.; Tuoni, C.; Filippi, L.; Ciantelli, M.; Tavanti, A.; Campa, D.
A polygenic risk score for multiple myeloma risk prediction 1-gen-2021 Canzian, F.; Piredda, C.; Macauda, A.; Zawirska, D.; Andersen, N. F.; Nagler, A.; Zaucha, J. M.; Mazur, G.; Dumontet, C.; Watek, M.; Jamroziak, K.; Sainz, J.; Varkonyi, J.; Butrym, A.; Beider, K.; Abildgaard, N.; Lesueur, F.; Dudzinski, M.; Vangsted, A. J.; Pelosini, M.; Subocz, E.; Petrini, M.; Buda, G.; Razny, M.; Gemignani, F.; Marques, H.; Orciuolo, E.; Kadar, K.; Jurczyszyn, A.; Druzd-Sitek, A.; Vogel, U.; Andersen, V.; Reis, R. M.; Suska, A.; Avet-Loiseau, H.; Kruszewski, M.; Tomczak, W.; Rymko, M.; Minvielle, S.; Campa, D.
Common gene variants within 3′-untranslated regions as modulators of multiple myeloma risk and survival 1-gen-2021 Melaiu, O.; Macauda, A.; Sainz, J.; Calvetti, D.; Facioni, M. S.; Maccari, G.; ter Horst, R.; Netea, M. G.; Li, Y.; Grzasko, N.; Moreno, V.; Jurczyszyn, A.; Jerez, A.; Watek, M.; Varkonyi, J.; Garcia-Sanz, R.; Kruszewski, M.; Dudzinski, M.; Kadar, K.; Jacobsen, S. E. H.; Mazur, G.; Andersen, V.; Rybicka, M.; Zawirska, D.; Razny, M.; Zaucha, J. M.; Ostrovsky, O.; Iskierka-Jazdzewska, E.; Reis, R. M.; Stepien, A.; Beider, K.; Nagler, A.; Druzd-Sitek, A.; Marques, H.; Martinez-Lopez, J.; Lesueur, F.; Avet-Loiseau, H.; Vangsted, A. J.; Krawczyk-Kulis, M.; Butrym, A.; Jamroziak, K.; Dumontet, C.; Vogel, U.; Rymko, M.; Pelosini, M.; Subocz, E.; Szombath, G.; Sarasquete, M. E.; Silvestri, R.; Morani, F.; Landi, S.; Campa, D.; Canzian, F.; Gemignani, F.
Drug-repositioning screening identified fludarabine and risedronic acid as potential therapeutic compounds for malignant pleural mesothelioma 1-gen-2021 Dell'Anno, I.; Martin, S. A.; Barbarino, M.; Melani, A.; Silvestri, R.; Bottaro, M.; Paolicchi, E.; Corrado, A.; Cipollini, M.; Melaiu, O.; Giordano, A.; Luzzi, L.; Gemignani, F.; Landi, S.